184 related articles for article (PubMed ID: 26169624)
1. Severe disturbance of glucose metabolism in peripheral blood mononuclear cells of schizophrenia patients: a targeted metabolomic study.
Liu ML; Zhang XT; Du XY; Fang Z; Liu Z; Xu Y; Zheng P; Xu XJ; Cheng PF; Huang T; Bai SJ; Zhao LB; Qi ZG; Shao WH; Xie P
J Transl Med; 2015 Jul; 13():226. PubMed ID: 26169624
[TBL] [Abstract][Full Text] [Related]
2. GC-MS based metabolomics identification of possible novel biomarkers for schizophrenia in peripheral blood mononuclear cells.
Liu ML; Zheng P; Liu Z; Xu Y; Mu J; Guo J; Huang T; Meng HQ; Xie P
Mol Biosyst; 2014 Jul; 10(9):2398-406. PubMed ID: 24975926
[TBL] [Abstract][Full Text] [Related]
3. Metabolite signature for diagnosing major depressive disorder in peripheral blood mononuclear cells.
Zheng P; Fang Z; Xu XJ; Liu ML; Du X; Zhang X; Wang H; Zhou J; Xie P
J Affect Disord; 2016 May; 195():75-81. PubMed ID: 26874244
[TBL] [Abstract][Full Text] [Related]
4. Peripheral blood mononuclear cell-based metabolomic profiling of a chronic unpredictable mild stress rat model of depression.
Li J; Tang G; Cheng K; Yang D; Chen G; Liu Z; Zhang R; Zhou J; Fang L; Fang Z; Du X; Xie P
Mol Biosyst; 2014 Nov; 10(11):2994-3001. PubMed ID: 25182291
[TBL] [Abstract][Full Text] [Related]
5. Determination of steroid metabolome as a possible tool for laboratory diagnosis of schizophrenia.
Bicikova M; Hill M; Ripova D; Mohr P; Hampl R
J Steroid Biochem Mol Biol; 2013 Jan; 133():77-83. PubMed ID: 22944140
[TBL] [Abstract][Full Text] [Related]
6. Divergent Urinary Metabolic Phenotypes between Major Depressive Disorder and Bipolar Disorder Identified by a Combined GC-MS and NMR Spectroscopic Metabonomic Approach.
Chen JJ; Zhou CJ; Liu Z; Fu YY; Zheng P; Yang DY; Li Q; Mu J; Wei YD; Zhou JJ; Huang H; Xie P
J Proteome Res; 2015 Aug; 14(8):3382-9. PubMed ID: 26168936
[TBL] [Abstract][Full Text] [Related]
7. The metabolites in peripheral blood mononuclear cells showed greater differences between patients with impaired fasting glucose or type 2 diabetes and healthy controls than those in plasma.
Kim M; Kim M; Han JY; Lee SH; Jee SH; Lee JH
Diab Vasc Dis Res; 2017 Mar; 14(2):130-138. PubMed ID: 28185532
[TBL] [Abstract][Full Text] [Related]
8. Impaired glycolytic response in peripheral blood mononuclear cells of first-onset antipsychotic-naive schizophrenia patients.
Herberth M; Koethe D; Cheng TM; Krzyszton ND; Schoeffmann S; Guest PC; Rahmoune H; Harris LW; Kranaster L; Leweke FM; Bahn S
Mol Psychiatry; 2011 Aug; 16(8):848-59. PubMed ID: 20585325
[TBL] [Abstract][Full Text] [Related]
9. Potential antidepressant and resilience mechanism revealed by metabolomic study on peripheral blood mononuclear cells of stress resilient rats.
Li J; Zhang SX; Wang W; Cheng K; Guo H; Rao CL; Yang DY; He Y; Zou DZ; Han Y; Zhao LB; Li PF; Xie P
Behav Brain Res; 2017 Mar; 320():12-20. PubMed ID: 27880890
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis of major depressive disorder based on changes in multiple plasma neurotransmitters: a targeted metabolomics study.
Pan JX; Xia JJ; Deng FL; Liang WW; Wu J; Yin BM; Dong MX; Chen JJ; Ye F; Wang HY; Zheng P; Xie P
Transl Psychiatry; 2018 Jul; 8(1):130. PubMed ID: 29991685
[TBL] [Abstract][Full Text] [Related]
11. Metabolomics tools for identifying biomarkers for neuropsychiatric diseases.
Quinones MP; Kaddurah-Daouk R
Neurobiol Dis; 2009 Aug; 35(2):165-76. PubMed ID: 19303440
[TBL] [Abstract][Full Text] [Related]
12. Discovery and validation of plasma biomarkers for major depressive disorder classification based on liquid chromatography-mass spectrometry.
Liu X; Zheng P; Zhao X; Zhang Y; Hu C; Li J; Zhao J; Zhou J; Xie P; Xu G
J Proteome Res; 2015 May; 14(5):2322-30. PubMed ID: 25784130
[TBL] [Abstract][Full Text] [Related]
13. Metabolomic profiling to identify potential serum biomarkers for schizophrenia and risperidone action.
Xuan J; Pan G; Qiu Y; Yang L; Su M; Liu Y; Chen J; Feng G; Fang Y; Jia W; Xing Q; He L
J Proteome Res; 2011 Dec; 10(12):5433-43. PubMed ID: 22007635
[TBL] [Abstract][Full Text] [Related]
14. Plasma metabonomics study of first-Episode schizophrenia treated with olanzapine in female patients.
Qiao Y; Zhang L; He S; Wen H; Yu YM; Cao CH; Li HF
Neurosci Lett; 2016 Mar; 617():270-6. PubMed ID: 26924724
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic model development for schizophrenia based on peripheral blood mononuclear cell subtype-specific expression of metabolic markers.
Zaki JK; Lago SG; Rustogi N; Gangadin SS; Benacek J; van Rees GF; Haenisch F; Broek JA; Suarez-Pinilla P; Ruland T; Auyeung B; Mikova O; Kabacs N; Arolt V; Baron-Cohen S; Crespo-Facorro B; Drexhage HA; de Witte LD; Kahn RS; Sommer IE; Bahn S; Tomasik J
Transl Psychiatry; 2022 Oct; 12(1):457. PubMed ID: 36310155
[TBL] [Abstract][Full Text] [Related]
16. Serum metabolomic profiling in acute alcoholic hepatitis identifies multiple dysregulated pathways.
Rachakonda V; Gabbert C; Raina A; Bell LN; Cooper S; Malik S; Behari J
PLoS One; 2014; 9(12):e113860. PubMed ID: 25461442
[TBL] [Abstract][Full Text] [Related]
17. Metabolomic analysis of biochemical changes in the plasma and urine of first-episode neuroleptic-naïve schizophrenia patients after treatment with risperidone.
Cai HL; Li HD; Yan XZ; Sun B; Zhang Q; Yan M; Zhang WY; Jiang P; Zhu RH; Liu YP; Fang PF; Xu P; Yuan HY; Zhang XH; Hu L; Yang W; Ye HS
J Proteome Res; 2012 Aug; 11(8):4338-50. PubMed ID: 22800120
[TBL] [Abstract][Full Text] [Related]
18. A novel urinary metabolite signature for diagnosing major depressive disorder.
Zheng P; Chen JJ; Huang T; Wang MJ; Wang Y; Dong MX; Huang YJ; Zhou LK; Xie P
J Proteome Res; 2013 Dec; 12(12):5904-11. PubMed ID: 24224655
[TBL] [Abstract][Full Text] [Related]
19. Predictive diagnosis of major depression using NMR-based metabolomics and least-squares support vector machine.
Zheng H; Zheng P; Zhao L; Jia J; Tang S; Xu P; Xie P; Gao H
Clin Chim Acta; 2017 Jan; 464():223-227. PubMed ID: 27931880
[TBL] [Abstract][Full Text] [Related]
20. Metabolic profiling identifies phospholipids as potential serum biomarkers for schizophrenia.
Wang D; Cheng SL; Fei Q; Gu H; Raftery D; Cao B; Sun X; Yan J; Zhang C; Wang J
Psychiatry Res; 2019 Feb; 272():18-29. PubMed ID: 30579177
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
